Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tue, 10/22/13 - 08:11 am
Novartis
guidance
Diovan
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Mon, 10/21/13 - 05:55 pm
Novartis
cyclin-dependent kinase inhibition [CDK]
Pfizer
palbociclib
LEE011
Atchoo! Who’s making money out of flu season
CNBC
Fri, 10/18/13 - 09:34 am
Flu
Novartis
GSK
Merck
Sanofi
AstraZeneca
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Cleveland Clinic
JNJ
Pharmacyclics
Novartis
serelaxin
ibrutinib
sofosbuvir
Gilead
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Parkinson's Disease
pimavanserin
Acadia
Duodopa
AbbVie
LCIG
AFQ056
Novartis
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
emerging markets
Bayer
Sanofi
Merck KGaA
GSK
Novartis
JNJ
Novo Nordisk
AstraZeneca
Pfizer
Roche
The Big Bucks in Keeping Kids Focused
Bloomberg/Businessweek
Fri, 10/11/13 - 08:50 am
ADHD
Shire
Vyvanse
Novartis
JNJ
Europe
Novartis - Make Money From COPD Opportunity
Seeking Alpha
Tue, 10/8/13 - 05:06 pm
COPD
Novartis
GSK
Theravance
Pfizer
Ultibro Breezhaler
Supreme Court Rejects Novartis Bid To Hear Punitive Damages Case
Pharmalot
Tue, 10/8/13 - 08:37 am
Novartis
Supreme Court
FDA
Novartis' omalizumab shines in third PhIII hives trial
Pharma Times, UK
Mon, 10/7/13 - 08:52 am
Novartis
chronic spontaneous urticaria
omalizumab
Xolair
Genentech
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Rexahn
chemotherapy
Amgen
Bristol-Myers Squibb
Merck
Novartis
Teva
RX-3117
Should Drugmakers Pay Punitive Damages? Novartis Says No Comment Now Follow Comments
Forbes
Sat, 10/5/13 - 09:51 am
Novartis
lawsuits
2 Companies Suffering From Generic Competition and 1 That's Set to Benefit
Motley Fool
Sat, 10/5/13 - 09:50 am
Novartis
generics
GSK
Ranbaxy
2 Companies Suffering From Generic Competition and 1 That's Set to Benefit
Motley Fool
Fri, 10/4/13 - 12:13 pm
generics
GSK
Novartis
Ranbaxy
Should Drugmakers Pay Punitive Damages? Novartis Says No
Pharmalot
Fri, 10/4/13 - 11:23 am
Novartis
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Novartis sees limited impact from Japan Diovan scandal
Reuters
Thu, 10/3/13 - 09:11 am
Novartis
Japan
Diovan
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Incyte
myelofibrosis
Jakafi
Novartis
Novartis May Have Violated Japanese Law With Diovan Marketing
Pharmalot
Tue, 10/1/13 - 10:12 am
Japan
Diovan
Novartis
Pages
« first
‹ previous
…
104
105
106
107
108
109
110
111
112
…
next ›
last »